IL158136A0 - Method for identification of proteins from intracellular bacteria - Google Patents
Method for identification of proteins from intracellular bacteriaInfo
- Publication number
- IL158136A0 IL158136A0 IL15813602A IL15813602A IL158136A0 IL 158136 A0 IL158136 A0 IL 158136A0 IL 15813602 A IL15813602 A IL 15813602A IL 15813602 A IL15813602 A IL 15813602A IL 158136 A0 IL158136 A0 IL 158136A0
- Authority
- IL
- Israel
- Prior art keywords
- proteins
- identification
- intracellular bacteria
- intracellular
- bacteria
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title 1
- 230000003834 intracellular effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Bioinformatics & Computational Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28251301P | 2001-04-09 | 2001-04-09 | |
| DKPA200100581 | 2001-04-09 | ||
| PCT/DK2002/000234 WO2002082091A2 (en) | 2001-04-09 | 2002-04-09 | Method for identification of proteins from intracellular bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL158136A0 true IL158136A0 (en) | 2004-03-28 |
Family
ID=26069005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15813602A IL158136A0 (en) | 2001-04-09 | 2002-04-09 | Method for identification of proteins from intracellular bacteria |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1412757A2 (en) |
| JP (1) | JP2004534526A (en) |
| KR (1) | KR20040002905A (en) |
| CN (1) | CN1531653A (en) |
| BR (1) | BR0208786A (en) |
| CA (1) | CA2443813A1 (en) |
| IL (1) | IL158136A0 (en) |
| MX (1) | MXPA03009222A (en) |
| WO (1) | WO2002082091A2 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| US7223745B2 (en) | 2003-08-14 | 2007-05-29 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| US7576206B2 (en) | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| GB0409748D0 (en) * | 2004-04-30 | 2004-06-09 | Chiron Srl | Lactoferrin cleavage |
| US7468383B2 (en) | 2005-02-11 | 2008-12-23 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| WO2008134085A1 (en) | 2007-05-01 | 2008-11-06 | Board Of Regents, University Of Texas System | Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease |
| US7892567B2 (en) | 2007-10-01 | 2011-02-22 | Board Of Regents, The University Of Texas System | Methods and compositions for immunization against chlamydial infection and disease |
| AU2009302821A1 (en) | 2008-10-09 | 2010-04-15 | Board Of Regents, University Of Texas System | Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease |
| WO2011087822A1 (en) | 2009-12-22 | 2011-07-21 | Cephalon, Inc. | Proteasome inhibitors and processes for their preparation, purification and use |
| CN102749233A (en) * | 2012-06-04 | 2012-10-24 | 王新华 | Pretreatment method for directly detecting infection urine pathogen by MALDI-TOF MS |
| NL2019320B1 (en) * | 2017-03-02 | 2018-09-21 | Biosparq B V | Diagnostic method and system for diagnosis |
| CN112175955B (en) * | 2020-10-29 | 2022-05-24 | 西南大学 | A strong promoter CP09 specifically expressed in plant pollen and its application |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001515064A (en) * | 1997-08-15 | 2001-09-18 | フランソワ・スーシー | Synthesis of clast-lactacystin β-lactone and analogs thereof |
| AU762606B2 (en) * | 1997-11-21 | 2003-06-26 | Genset S.A. | Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| WO1999028475A2 (en) * | 1997-11-28 | 1999-06-10 | Genset | Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
-
2002
- 2002-04-09 MX MXPA03009222A patent/MXPA03009222A/en unknown
- 2002-04-09 KR KR10-2003-7013236A patent/KR20040002905A/en not_active Withdrawn
- 2002-04-09 WO PCT/DK2002/000234 patent/WO2002082091A2/en not_active Ceased
- 2002-04-09 CN CNA028091140A patent/CN1531653A/en active Pending
- 2002-04-09 IL IL15813602A patent/IL158136A0/en unknown
- 2002-04-09 BR BR0208786-3A patent/BR0208786A/en not_active IP Right Cessation
- 2002-04-09 EP EP02759766A patent/EP1412757A2/en not_active Withdrawn
- 2002-04-09 JP JP2002579810A patent/JP2004534526A/en active Pending
- 2002-04-09 CA CA002443813A patent/CA2443813A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002082091A2 (en) | 2002-10-17 |
| BR0208786A (en) | 2004-03-09 |
| EP1412757A2 (en) | 2004-04-28 |
| CA2443813A1 (en) | 2002-10-17 |
| WO2002082091A3 (en) | 2004-03-04 |
| MXPA03009222A (en) | 2004-11-12 |
| CN1531653A (en) | 2004-09-22 |
| KR20040002905A (en) | 2004-01-07 |
| JP2004534526A (en) | 2004-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1464702A4 (en) | Method of stabilizing protein | |
| WO2003032240A8 (en) | Methods and apparatuses for identification | |
| IL157894A0 (en) | Method for identifying inhibitors of g protein coupled receptor signalling | |
| IL200255A (en) | Method of preparing o-desmethyl-venlafaxine | |
| IL158136A0 (en) | Method for identification of proteins from intracellular bacteria | |
| PL1527690T3 (en) | Method of deflavoring whey protein | |
| GB2381111B (en) | Method of providing information | |
| AU2002364749A8 (en) | Method for protein expression analysis | |
| EP1366360A4 (en) | Methods for large scale protein matching | |
| AU2002302502A1 (en) | Method for identification or authentication | |
| AUPR966701A0 (en) | Identification method | |
| IL158004A0 (en) | Method of enhancing entomophilous | |
| AU2002354363A1 (en) | Method of activating protein | |
| AUPR866001A0 (en) | Hide identification system | |
| HK1065592A (en) | Method for identification of proteins from intracellular bacteria | |
| GB2371731B (en) | Method of alignment | |
| AU2002355475A1 (en) | Method for identification of protein function | |
| GB0220456D0 (en) | An object identification method | |
| AU2002364192A8 (en) | Method of identifying novel proteins | |
| GB0124821D0 (en) | Automated identification of microtubes | |
| GB0127930D0 (en) | Method for detecting prion protein | |
| GB0224094D0 (en) | Automated identification of microtubes | |
| AUPR730401A0 (en) | Novel method for identification of protein-protein interaction sites | |
| GB0025328D0 (en) | Automated identification of microtubes | |
| PL347006A1 (en) | Method of obtaining cephazidime containing eye drops |